1. Home
  2. RWT vs VIR Comparison

RWT vs VIR Comparison

Compare RWT & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwood Trust Inc.

RWT

Redwood Trust Inc.

HOLD

Current Price

$5.62

Market Cap

693.0M

Sector

Real Estate

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.78

Market Cap

773.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RWT
VIR
Founded
1994
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
693.0M
773.5M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
RWT
VIR
Price
$5.62
$6.78
Analyst Decision
Buy
Strong Buy
Analyst Count
8
11
Target Price
$7.00
$25.73
AVG Volume (30 Days)
1.1M
1.8M
Earning Date
10-29-2025
11-05-2025
Dividend Yield
12.86%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$120,897,000.00
$16,860,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$46.22
$48.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.68
$4.16
52 Week High
$7.19
$14.45

Technical Indicators

Market Signals
Indicator
RWT
VIR
Relative Strength Index (RSI) 58.59 61.51
Support Level $5.45 $6.49
Resistance Level $5.70 $6.89
Average True Range (ATR) 0.13 0.47
MACD 0.03 0.06
Stochastic Oscillator 86.72 83.17

Price Performance

Historical Comparison
RWT
VIR

About RWT Redwood Trust Inc.

Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: